[Idiopathic and drug-induced acquired aplastic anemia. 2].
D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D001241:Aspirin / Q000009:adverse effects; D001856:Bone Marrow Examination; D002701:Chloramphenicol / Q000009:adverse effects; D002744:Chlorpheniramine / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D006046:Gold / Q000009:adverse effects; D006454:Hemoglobins; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D008875:Middle Aged; D010406:Penicillins / Q000009:adverse effects; D010615:Phenacetin / Q000009:adverse effects; D011379:Prognosis; D013444:Sulfisoxazole / Q000009:adverse effects; D013557:Switzerland; D013752:Tetracycline / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects
D006454:Hemoglobins; D006827:Hydantoins; D010406:Penicillins; D002744:Chlorpheniramine; D002701:Chloramphenicol; D013444:Sulfisoxazole; D006046:Gold; D014044:Tolbutamide; D010615:Phenacetin; D013752:Tetracycline; D001241:Aspirin; D002746:Chlorpromazine
Idiopathische und medikamentös bedingte erworbene aplastische Anämien. 2.